Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-06

FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for palonosetron hydrochloride submitted by Cipla USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)